Andrés Lamsfus‐Calle

Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors

Justin S. Antony, Ngadhnjim Latifi, A.K.M. Ashiqul Haque et al. · Molecular and Cellular Pediatrics · 2018 · 54 citations · Full text

Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin

Andrés Lamsfus‐Calle, Alberto Daniel-Moreno, Justin S. Antony et al. · Scientific Reports · 2020 · 53 citations · Full text

CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies

Guillermo Ureña-Bailén, Andrés Lamsfus‐Calle, Alberto Daniel-Moreno et al. · Briefings in Functional Genomics · 2019 · 18 citations

Immunology, New Generation, Immune Cell Therapy +20

CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases

Justin S. Antony, A. K. M. Ashiqul Haque, Andrés Lamsfus‐Calle et al. · Advances in Cell and Gene Therapy · 2018 · 17 citations · Full text

Off-target Effect, Crispr/cas9 System, Engineering +12

A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy

Justin S. Antony, Alberto Daniel-Moreno, Andrés Lamsfus‐Calle et al. · The CRISPR Journal · 2021 · 12 citations